Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Metastatic Breast Cancer:
women \>=18 years of age
Patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy.
Previous therapy should have included an anthracycline.
Patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.
Female patients with histopathologically proven metastatic breast cancer
Adequate bone marrow, liver, renal and cardiac functions
Colon Cancer:
Patients \>18 years of age
Patients with histologicaly confirmed colon cancer
Patients with potential curative tumor resection within 8 weeks before enrolment in the study
Patients previously not treated with chemiotherapy
You may not be if
Metastatic Breast Cancer:
Patients previously treated with docetaxel (Taxotere) or capecitabine (Xeloda)
Patients with contraindications for any of study drugs as listed in approved SmPC
Colon Cancer:
Patients previously treated with chemiotherapy
Patients with contraindications for study drug as listed in approved SmPC
